We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current ANIK market cap is 372.32M. The company's latest EPS is USD -5.6463 and P/E is -4.51.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 40.26M | 39.62M | 37.92M | 44.3M | 41.47M |
| Operating Income | -5.8M | -6.67M | -12.55M | -3.63M | -7.67M |
| Net Income | -4.18M | -4.91M | -10.35M | -2.74M | -6.58M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 114.61M | 159.12M | 168.89M | 156.24M | 166.66M |
| Operating Income | 34.25M | -28.32M | 2.62M | -19.4M | -87.64M |
| Net Income | 27.19M | -23.98M | 4.13M | -14.86M | -82.67M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 347.75M | 349.13M | 339.07M | 328.88M | 328.16M |
| Total Liabilities | 62.81M | 63.57M | 61.49M | 54.87M | 57.67M |
| Total Equity | 284.94M | 285.56M | 277.59M | 274.02M | 270.49M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 330.71M | 365.61M | 347.54M | 349.13M | 270.63M |
| Total Liabilities | 42.33M | 93.21M | 60.45M | 63.57M | 58.37M |
| Total Equity | 288.38M | 272.4M | 287.09M | 285.56M | 212.27M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 3.93M | 4.41M | -3.62M | -11.91M | -5.43M |
| Investing | -4.96M | -7.49M | -1.39M | -2.85M | -3.59M |
| Financing | -5.52M | -4.85M | -1.61M | -6.56M | -6.67M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 37.01M | 13.07M | 8.4M | 4.41M | -1.79M |
| Investing | 39.69M | -71.26M | -3.12M | -7.49M | -5.43M |
| Financing | -8.14M | -3.77M | -6.78M | -4.85M | -6.32M |
| Market Cap | 372.32M |
| Price to Earnings Ratio | -4.51 |
| Price to Sales Ratio | 2.24 |
| Price to Cash Ratio | 5.12 |
| Price to Book Ratio | 1.76 |
| Dividend Yield | - |
| Shares Outstanding | 14.64M |
| Average Volume (1 week) | 53.95k |
| Average Volume (1 Month) | 70.39k |
| 52 Week Change | -7.96% |
| 52 Week High | 28.70 |
| 52 Week Low | 16.54 |
| Spread (Intraday) | 1.02 (3.93%) |
| Company Name | Anika Therapeutics Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://anika.com |
| Industry | surgical,med instr,apparatus (3841) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
